A Post Market Surveillance Study About the MONOCER Cup

Launched by MEDACTA INTERNATIONAL SA · Mar 24, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new implant called the Mpact 3D Metal MonoCER cup, which is used in total hip replacements. The aim is to see how well this new design works, especially since larger parts can help reduce the risk of hip dislocation during movement. The MonoCER cup is designed to make surgery easier and more efficient by combining the cup and the insert into one piece, which could lead to better outcomes for patients.

To participate in this study, you need to be between 65 and 75 years old and scheduled for a total hip replacement using the MonoCER cup. You must also be able to understand and agree to take part in the study by signing a consent form. If you decide to join, you can expect to be monitored closely after your surgery to help researchers learn more about how this new implant performs over time. This trial is currently recruiting participants, and your involvement could contribute to important findings that may improve hip replacement procedures in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients undergoing total hip arthroplasty who will receive the Mpact 3D Metal MonoCER acetabular component according to the instructions for use
• • 2. Patients who have signed the informed consent to participate in the study
• Exclusion Criteria:
• • 1. Minor patients, patients over 75 years of age at the time of primary surgery;
• • 2. Any patient who is unable or unwilling to give informed consent to participate in the study.